Boehringer settles FTC claims on asset swap

 

By News-Press Now

Boehringer Ingelheim agreed to divest of five types of animal health products in order to settle regulatory concerns that an asset swap would reduce competition in the U.S. market.

FULL STORY

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s